Dr. Joseph C. Maroon Joins Lionheart Health's Scientific and Clinical Advisory Board

Dr. Joseph C. Maroon, a renowned neurosurgeon and longevity scientist, joins Lionheart Health's advisory board to advance bioelectric therapies for brain health and healthspan extension.

DC Metrowire Staff
Healthcare
Dr. Joseph C. Maroon Joins Lionheart Health's Scientific and Clinical Advisory Board

Lionheart Health, Inc., a leader in bioelectric regenerative medicine and healthspan optimization, announced that Joseph C. Maroon, MD, FACS, has joined its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon, Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center (UPMC), and longtime Team Neurosurgeon for the Pittsburgh Steelers. He is internationally recognized for his work in brain health, sports neurosurgery, concussion management, neuroinflammation, and longevity science.

Dr. Maroon's appointment reinforces Lionheart Health's commitment to evidence-based bioelectric stimulation therapies targeting cognition, memory, mood, neuroplasticity, and inflammation reduction. The company's platform includes BodStim™ and Brain Band™ technologies that align with Dr. Maroon's focus on neuroprotection and performance longevity. According to Howard Leonhardt, Founder and Executive Chairman of Lionheart Health, Dr. Maroon's "decades of leadership in neurosurgery and preventive brain health bring exceptional scientific credibility and clinical insight."

Lionheart Health is advancing clinical initiatives to improve functional biomarkers of aging such as grip strength, gait speed, cognition, and inflammatory markers. Dr. Maroon will advise on brain health study design, neurocognitive endpoint validation, concussion applications, and integration of lifestyle and bioelectric strategies. He stated, "Optimizing brain health is central to extending meaningful healthspan. I look forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies."

The company's intellectual property portfolio includes patents targeting regenerative pathways like Klotho, BDNF, and eNOS. Lionheart Health is competing in the XPRIZE Healthspan Competition and was recognized as 2025 Micro Stimulator Developer of the Year by Medtech Outlook. The company has completed pre-clinical studies and a pilot clinical trial in Brazil, with plans to enroll in a combination BodStim™ and Brain Band™ trial for brain health.

Dr. Maroon brings over four decades of experience in academic neurosurgery, with more than 300 peer-reviewed publications and multiple textbooks. His research has advanced understanding of neuroinflammation, omega-3 fatty acids, and integrative strategies for cognitive function. His thought leadership in proactive brain health aligns with Lionheart Health's mission to extend healthy years of life through regenerative signaling.

Blockchain Registration

QR Code for Blockchain Registration